With our in-house technology platform, scientific expertise in the inner ear, and network of experts, Sensorion can continually develop and optimize its pipeline and market expertise. Consequently, we are poised to expand our pipeline and facilitate other pharmaceutical collaborations.

We select and develop drug candidates from a pool of compounds in late pre-clinical and clinical stage development obtained from partnerships, collaborations and publically available drug libraries.

20201104 Pipeline


Latest news

  • 20 Nov 2020

    Sensorion Hosting Key Opinon Leader Call with Dr. John Greinwald on Genetic Hearing Loss in Children on December 2, 2020. Read

  • 18 Nov 2020

    Balance of the liquidity contract to June 30, 2020. Read

Patient center

Corporate presentation